DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Bae ON.
Targeting von Willebrand factor as a novel anti-platelet therapy; application of ARC1779, an anti-vWF aptamer, against thrombotic risk.
Arch Pharm Res 2012;
35: 1693-1699.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.